2nd dose of J&J COVID-19 vaccine results in stronger protection, company says

  • 📰 YahooNews
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 59%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

New data suggests two Johnson & Johnson shots, given two months apart, results in 94% protection against any symptomatic COVID infection in the U.S., and 100% against severe disease.

Compared to the Pfizer and Moderna vaccines, Johnson & Johnson's single-shot vaccine always had slightly lower efficacy. Peak efficacy from the two-shot Pfizer and Moderna vaccines was 95% and 94%, respectively, against symptomatic illness.

All three currently authorized vaccines are still working well to dramatically reduce the risk of being hospitalized, but as months pass and with the emergence of new COVID-19 variants, the vaccines are losing their power to prevent more mild breakthrough infections. PHOTO: FILE - In this July 30, 2021, file photo, Jay Vojno gets the Johnson & Johnson COVID-19 vaccine, in New York.

MORE: Johnson & Johnson vaccine seems to stand up against delta variant, preliminary research suggests

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

HiMyNameIsSeton 'suggests'

Got my J&J shot over six months ago and still wondering why they’re not talking about boosters for us. I almost feel like lying about my vaccine status and just getting one shot of Pfizer or Moderna.

chazkellyisms 🕺

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 380. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines